Table 1.
Association of MRPS16 expression with clinicopathological characteristics in human glioma.
Features | No. | MRPS16 | P-value | |
---|---|---|---|---|
Low | High | |||
Age(years) | ||||
<50 | 33 | 17 | 16 | 0.91 |
>=50 | 28 | 14 | 14 | |
Gender | ||||
Male | 27 | 14 | 13 | 0.89 |
Female | 34 | 17 | 17 | |
Tumor size, cm | ||||
<3 | 37 | 24 | 13 | 0.006 |
>=3 | 24 | 7 | 17 | |
Tumor location | ||||
Supratentorial | 39 | 18 | 21 | 0.33 |
Subtentorial | 22 | 13 | 9 | |
Karnofsky performance scale | ||||
<90 | 38* | 15 | 23* | 0.01 |
>=90 | 22 | 16 | 6 | |
WHO grade | ||||
Low-grade(I+II) | 35 | 23 | 12 | 0.007 |
High-grade(III+IV) | 26 | 8 | 18 | |
Tumor recurrence | ||||
No | 42* | 27* | 15 | 0.001 |
Yes | 18 | 3 | 15 |
* Partial data not available; statistics based on available data.